Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required
- PMID: 1768273
- DOI: 10.1016/0006-2952(91)90406-u
Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required
Abstract
Nitric oxide (NO) was produced from sodium nitroprusside in the presence of vascular tissue but was not released spontaneously from the nitroprusside anion. In the absence of tissue in the dark nitroprusside did not release NO. When solutions of nitroprusside alone were irradiated with visible light, nitric oxide was released at rates linearly proportional to nitroprusside concentration and light intensity. Nitric oxide was produced from solutions of nitroprusside in the dark after the addition of vascular tissue, including lengths of rabbit aorta, subcellular fractions of aorta, and human plasma. NO was also released from nitroprusside after reaction with various reducing agents including cysteine and other thiols, ascorbic acid, sodium dithionite, ferrous chloride, hemoglobin, myoglobin, and partially purified cytochrome P450 with an NADPH-regenerating system. HCN was simultaneously produced in these solutions, and addition of KCN blocked NO release. Iodine oxidized intermediate cyanoferrates and blocked nitric oxide release. KCN or iodine also blocked NO production by tissue, but had no effect upon photochemical NO release. These results show that, apart from photolysis which makes no physiological contribution, release of nitric oxide from nitroprusside, in simple solutions and in biological tissue, occurs after nitroprusside has undergone reduction and lost cyanide.
Similar articles
-
Production of nitric oxide and other iron-containing metabolites during the reductive metabolism of nitroprusside by microsomes and by thiols.Arch Biochem Biophys. 1995 Aug 20;321(2):363-71. doi: 10.1006/abbi.1995.1406. Arch Biochem Biophys. 1995. PMID: 7646061
-
Quantitation of nitric oxide by a computerized chemiluminescence detector measurement of photolytic degradation of streptozotocin and sodium nitroprusside to release nitric oxide.Proc West Pharmacol Soc. 1993;36:203-7. Proc West Pharmacol Soc. 1993. PMID: 8378379 No abstract available.
-
Photodegradation of sodium nitroprusside: biologic activity and cyanide release.Anesthesiology. 1984 Sep;61(3):254-60. doi: 10.1097/00000542-198409000-00004. Anesthesiology. 1984. PMID: 6089613
-
Sodium nitroprusside in 2014: A clinical concepts review.J Anaesthesiol Clin Pharmacol. 2014 Oct;30(4):462-71. doi: 10.4103/0970-9185.142799. J Anaesthesiol Clin Pharmacol. 2014. PMID: 25425768 Free PMC article. Review.
-
Nitroprusside, antihypertensive drug and analytical reagent. Review of (photo)stability, pharmacology and analytical properties.Pharm Weekbl Sci. 1984 Aug 24;6(4):129-40. doi: 10.1007/BF01954040. Pharm Weekbl Sci. 1984. PMID: 6384923 Review.
Cited by
-
The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death.Arthritis Res Ther. 2005;7(3):R526-35. doi: 10.1186/ar1705. Epub 2005 Mar 1. Arthritis Res Ther. 2005. PMID: 15899039 Free PMC article.
-
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.Int J Infect Dis. 2004 Jul;8(4):223-6. doi: 10.1016/j.ijid.2004.04.012. Int J Infect Dis. 2004. PMID: 15234326 Free PMC article.
-
Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL-penicillamine and sodium nitroprusside under hypoxic conditions.Biochem J. 1996 Sep 15;318 ( Pt 3)(Pt 3):789-95. doi: 10.1042/bj3180789. Biochem J. 1996. PMID: 8836121 Free PMC article.
-
The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.Trials. 2014 Sep 25;15:371. doi: 10.1186/1745-6215-15-371. Trials. 2014. PMID: 25252600 Free PMC article. Clinical Trial.
-
MicroRNA-1 participates in nitric oxide-induced apoptotic insults to MC3T3-E1 cells by targeting heat-shock protein-70.Int J Biol Sci. 2015 Jan 15;11(3):246-55. doi: 10.7150/ijbs.11138. eCollection 2015. Int J Biol Sci. 2015. PMID: 25678843 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources